Interpolymer complexes of eudragit® copolymers as novel carriers for colon-specific drug delivery

24Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Interpolymer complexes (IPC) based on Eudragit® EPO and Eudragit® S100were investigated as potential carriers for oral controlled drug delivery to the colon. IPC samples were prepared by mixing copolymer solutions in organic solvents (ethanol, isopropanol:acetone mixture (60:40, % v/v) and tetrahydrofuran). According to the data of elemental analysis, FTIR-spectroscopy, X-ray photoelectron spectroscopy and thermal analysis these IPCs have excess of anionic copolymer (Eudragit® S100) in their structure; they are stabilized by hydrogen and ionic intermacromolecular bonds and do not include free copolymer domains. IPC have pH-independent swelling properties in the media mimicking gastrointestinal tract (GIT) conditions and provide colon-specific delivery of indomethacin in buffer solutions (pH 1.2; 5.8; 6.8; 7.4) and in biorelevant media (fasted state simulated gastric fluid, fasted state simulated intestinal fluid-version 2 and fasted stated simulated colonic fluid).

Cite

CITATION STYLE

APA

Bukhovets, A. V., Fotaki, N., Khutoryanskiy, V. V., & Moustafine, R. I. (2020). Interpolymer complexes of eudragit® copolymers as novel carriers for colon-specific drug delivery. Polymers, 12(7), 1–16. https://doi.org/10.3390/polym12071459

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free